Brief: Inozyme Pharma Announces Presentation Of Interim Data From Phase 1 Seaport 1 Trial At The Upcoming American Society Of Nephrology (ASN) Kidney Week 2024
17/10/2024 13:36
Oct 17 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA ANNOUNCES PRESENTATION OF INTERIM DATA FROM
PHASE
1 SEAPORT 1 TRIAL AT THE UPCOMING AMERICAN SOCIETY OF NEPHROLOGY
(ASN) KIDNEY WEEK 2024
Source text for Eikon: ID:nGNXw3t9q
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin